Search research articles
Contact Us
Filters
Showing results (301-310 of 309) with videos related to
Page
of 31
Sort By:
You have reached the last page of results.
This site can display upto 309 results.
Cell Death & Disease
|
November 30, 2024
A N7-methylguanosine modified circular RNA, circIPP2A2, promotes malignant behaviors in hepatocellular carcinoma by serving as a scaffold in modulating the Hornerin/PI3K/AKT/GSK3β axis
Zeyi Guo, Zhongzhe Li, Jinhao Guo, et al.
Chest
|
November 9, 2017
HDAC2 Suppresses IL17A-Mediated Airway Remodeling in Human and Experimental Modeling of COPD
Tianwen Lai, Baoping Tian, Chao Cao, et al.
The Lancet. Respiratory Medicine
|
October 13, 2014
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
Mario Castro, Sally E Wenzel, Eugene R Bleecker, et al.
Thorax
|
August 8, 2020
Induction of ferroptosis-like cell death of eosinophils exerts synergistic effects with glucocorticoids in allergic airway inflammation
Yanping Wu, Haixia Chen, Nanxia Xuan, et al.
Science Translational Medicine
|
May 27, 2021
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
Jodi L Karnell, Yanping Wu, Nanette Mittereder, et al.
Nature Communications
|
April 16, 2025
Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis
Zhan Zhao, Jiashuai He, Shenghui Qiu, et al.
The New England Journal of Medicine
|
November 14, 2024
Inebilizumab for Treatment of IgG4-Related Disease
John H Stone, Arezou Khosroshahi, Wen Zhang, et al.
Thorax
|
October 20, 2020
MTOR suppresses autophagy-mediated production of IL25 in allergic airway inflammation
Wen Li, Yinfang Wu, Yun Zhao, et al.
The Lancet. Respiratory Medicine
|
September 12, 2024
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
Baohui Han, Trevor Feinstein, Yuankai Shi, et al.
Page
of 31
Search research articles
Search
Showing results (301-310 of 309) with videos related to
Sort By:
Page
of 31
You have reached the last page of results.
This site can display upto 309 results.
Cell Death & Disease
|
November 30, 2024
A N7-methylguanosine modified circular RNA, circIPP2A2, promotes malignant behaviors in hepatocellular carcinoma by serving as a scaffold in modulating the Hornerin/PI3K/AKT/GSK3β axis
Zeyi Guo, Zhongzhe Li, Jinhao Guo, et al.
Chest
|
November 9, 2017
HDAC2 Suppresses IL17A-Mediated Airway Remodeling in Human and Experimental Modeling of COPD
Tianwen Lai, Baoping Tian, Chao Cao, et al.
The Lancet. Respiratory Medicine
|
October 13, 2014
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
Mario Castro, Sally E Wenzel, Eugene R Bleecker, et al.
Thorax
|
August 8, 2020
Induction of ferroptosis-like cell death of eosinophils exerts synergistic effects with glucocorticoids in allergic airway inflammation
Yanping Wu, Haixia Chen, Nanxia Xuan, et al.
Science Translational Medicine
|
May 27, 2021
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
Jodi L Karnell, Yanping Wu, Nanette Mittereder, et al.
Nature Communications
|
April 16, 2025
Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis
Zhan Zhao, Jiashuai He, Shenghui Qiu, et al.
The New England Journal of Medicine
|
November 14, 2024
Inebilizumab for Treatment of IgG4-Related Disease
John H Stone, Arezou Khosroshahi, Wen Zhang, et al.
Thorax
|
October 20, 2020
MTOR suppresses autophagy-mediated production of IL25 in allergic airway inflammation
Wen Li, Yinfang Wu, Yun Zhao, et al.
The Lancet. Respiratory Medicine
|
September 12, 2024
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
Baohui Han, Trevor Feinstein, Yuankai Shi, et al.
Page
of 31